Clinical trial
Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis
NCT03914638 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis
- Lead sponsor
- University of Aarhus
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- April 1, 2019
- Completion date
- October 31, 2021
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.